U.S. Dry Eye Syndrome Treatment Market (2025 - 2030) Size, Share & Trends Analysis Report By Type (Evaporative Dry Eye Syndrome), By Drugs (Restasis, Xiidra), By Product (Cyclosporine), By Dosage Form, By Sales Channel, By Distribution Channel, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Type
                       1.2.2. Drugs
                       1.2.3. Product
                       1.2.4. Dosage Form
                       1.2.5. Sales Channel
                       1.2.6. Distribution Channel
                   1.3. Estimates and Forecast Timeline
                   1.4. Research Methodology
                   1.5. Information Procurement
                       1.5.1. Purchased Database
                       1.5.2. GVR’s Internal Database
                       1.5.3. Secondary Sources
                       1.5.4. Primary Research
                   1.6. Information Analysis
                       1.6.1. Data Analysis Models
                   1.7. Market Formulation & Data Visualization
                   1.8. Model Details
                       1.8.1. Commodity Flow Analysis
                   1.9. List of Secondary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Snapshot
                   2.2. Segment Snapshot
                   2.3. Competitive Landscape Snapshot
Chapter 3. U.S. Dry Eye Syndrome Treatment Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                       3.2.2. Market Restraint Analysis
                   3.3. Business Environment Analysis
                       3.3.1. Industry Analysis - Porter’s Five Forces Analysis
                           3.3.1.1. Supplier Power
                           3.3.1.2. Buyer Power
                           3.3.1.3. Substitution Threat
                           3.3.1.4. Threat of New Entrants
                           3.3.1.5. Competitive Rivalry
                       3.3.2. PESTLE Analysis
Chapter 4. U.S. Dry Eye Syndrome Treatment Market: Type Business Analysis
                   4.1. Type Market Share, 2024 & 2030
                   4.2. Type Segment Dashboard
                   4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
                   4.4. Evaporative
                       4.4.1. Evaporative Market, 2018 - 2030 (USD Million)
                   4.5. Aqueous Deficient
                       4.5.1. Aqueous Deficient Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Dry Eye Syndrome Treatment Market: Drugs Business Analysis
                   5.1. Drugs Market Share, 2024 & 2030
                   5.2. Drugs Segment Dashboard
                   5.3. Market Size & Forecasts and Trend Analysis, by Drugs, 2018 to 2030 (USD Million)
                   5.4. Xiidra
                       5.4.1. Xiidra Market, 2018 - 2030 (USD Million)
                   5.5. Restasis
                       5.5.1. Restasis Market, 2018 - 2030 (USD Million)
                   5.6. Cequa
                       5.6.1. Cequa Market, 2018 - 2030 (USD Million)
                   5.7. Tyrvaya
                       5.7.1. Tyrvaya Market, 2018 - 2030 (USD Million)
                   5.8. Eysuvis
                       5.8.1. Eysuvis Market, 2018 - 2030 (USD Million)
                   5.9. Others
                       5.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Dry Eye Syndrome Treatment Market: Product Business Analysis
                   6.1. Product Market Share, 2024 & 2030
                   6.2. Product Segment Dashboard
                   6.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
                   6.4. Artificial Tears
                       6.4.1. Artificial Tears Market, 2018 - 2030 (USD Million)
                   6.5. Cyclosporine
                       6.5.1. Cyclosporine Market, 2018 - 2030 (USD Million)
                   6.6. Topical Corticosteroids
                       6.6.1. Topical Corticosteroids Market, 2018 - 2030 (USD Million)
                   6.7. Punctal Plugs
                       6.7.1. Punctal Plugs Market, 2018 - 2030 (USD Million)
                       6.7.2. Removable
                           6.7.2.1. Removable Market, 2018 - 2030 (USD Million)
                       6.7.3. Dissolvable
                           6.7.3.1. Dissolvable Market, 2018 - 2030 (USD Million)
                   6.8. Oral Omega Supplements
                       6.8.1. Oral Omega Supplements Market, 2018 - 2030 (USD Million)
                   6.9. Others
                       6.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. U.S. Dry Eye Syndrome Treatment Market: Dosage Form Business Analysis
                   7.1. Dosage Form Market Share, 2024 & 2030
                   7.2. Dosage Form Segment Dashboard
                   7.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2018 to 2030 (USD Million)
                   7.4. Eye Drops / Solutions
                       7.4.1. Eye Drops / Solutions Market, 2018 - 2030 (USD Million)
                   7.5. Ointments and Gels
                       7.5.1. Ointments and Gels Market, 2018 - 2030 (USD Million)
                   7.6. Capsules & Tablets
                       7.6.1. Capsules & Tablets Market, 2018 - 2030 (USD Million)
                   7.7. Others
                       7.7.1. Others Market, 2018 - 2030 (USD Million) Market, 2018 - 2030 (USD Million)
Chapter 8. U.S. Dry Eye Syndrome Treatment Market: Sales Channel Business Analysis
                   8.1. Sales Channel Market Share, 2024 & 2030
                   8.2. Sales Channel Segment Dashboard
                   8.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
                   8.4. Prescription
                       8.4.1. Prescription Market, 2018 - 2030 (USD Million)
                   8.5. OTC
                       8.5.1. OTC Market, 2018 - 2030 (USD Million)
Chapter 9. U.S. Dry Eye Syndrome Treatment Market: Distribution Channel Business Analysis
                   9.1. Distribution Channel Market Share, 2024 & 2030
                   9.2. Distribution Channel Segment Dashboard
                   9.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
                   9.4. Retail Pharmacies
                       9.4.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
                   9.5. Hospital Pharmacies
                       9.5.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
                   9.6. Online Pharmacies
                       9.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
                   10.1. Participant Overview
                   10.2. Company Market Position Analysis
                   10.3. Company Categorization
                   10.4. Strategy Mapping
                   10.5. Company Profiles/Listing
                       10.5.1. Novartis AG
                           10.5.1.1. Overview
                           10.5.1.2. Financial Performance
                           10.5.1.3. Product Benchmarking
                           10.5.1.4. Strategic Initiatives
                       10.5.2. AbbVie Inc.
                           10.5.2.1. Overview
                           10.5.2.2. Financial Performance
                           10.5.2.3. Product Benchmarking
                           10.5.2.4. Strategic Initiatives
                       10.5.3. Sun Pharmaceutical Industries Ltd.
                           10.5.3.1. Overview
                           10.5.3.2. Financial Performance
                           10.5.3.3. Product Benchmarking
                           10.5.3.4. Strategic Initiatives
                       10.5.4. Janssen Pharmaceutica (Pty.) Ltd.
                           10.5.4.1. Overview
                           10.5.4.2. Financial Performance
                           10.5.4.3. Product Benchmarking
                           10.5.4.4. Strategic Initiatives
                       10.5.5. OASIS Medical, Inc.
                           10.5.5.1. Overview
                           10.5.5.2. Financial Performance
                           10.5.5.3. Product Benchmarking
                           10.5.5.4. Strategic Initiatives
                       10.5.6. Viatris Inc.
                           10.5.6.1. Overview
                           10.5.6.2. Financial Performance
                           10.5.6.3. Product Benchmarking
                           10.5.6.4. Strategic Initiatives
                       10.5.7. Bausch Health Companies Inc.
                           10.5.7.1. Overview
                           10.5.7.2. Financial Performance
                           10.5.7.3. Product Benchmarking
                           10.5.7.4. Strategic Initiatives
                       10.5.8. Santen Pharmaceutical Co., Ltd.
                           10.5.8.1. Overview
                           10.5.8.2. Financial Performance
                           10.5.8.3. Product Benchmarking
                           10.5.8.4. Strategic Initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. dry eye syndrome treatment market, by region, 2018 - 2030 (USD Million)
Table 4. U.S. dry eye syndrome treatment market, by type, 2018 - 2030 (USD Million)
Table 5. U.S. dry eye syndrome treatment market, by drugs, 2018 - 2030 (USD Million)
Table 6. U.S. dry eye syndrome treatment market, by product, 2018 - 2030 (USD Million)
Table 7. U.S. dry eye syndrome treatment market, by dosage form, 2018 - 2030 (USD Million)
Table 8. U.S. dry eye syndrome treatment market, by sales channel, 2018 - 2030 (USD Million)
Table 9. U.S. dry eye syndrome treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. dry eye syndrome treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Type and drugs outlook (USD Million)
Fig. 10 Product and dosage form outlook (USD Million)
Fig. 11 Sales channel and distribution channel outlook (USD Million)
Fig. 12 Competitive landscape
Fig. 13 U.S. dry eye syndrome treatment market dynamics
Fig. 14 U.S. dry eye syndrome treatment market: Porter’s five forces analysis
Fig. 15 U.S. dry eye syndrome treatment market: PESTLE analysis
Fig. 16 U.S. dry eye syndrome treatment market: Type segment dashboard
Fig. 17 U.S. dry eye syndrome treatment market: Type market share analysis, 2024 & 2030
Fig. 18 U.S. dry eye syndrome treatment market: Drugs segment dashboard
Fig. 19 U.S. dry eye syndrome treatment market: Drugs market share analysis, 2024 & 2030
Fig. 20 U.S. dry eye syndrome treatment market: Product segment dashboard
Fig. 21 U.S. dry eye syndrome treatment market: Product market share analysis, 2024 & 2030
Fig. 22 U.S. dry eye syndrome treatment market: Dosage form segment dashboard
Fig. 23 U.S. dry eye syndrome treatment market: Dosage form market share analysis, 2024 & 2030
Fig. 24 U.S. dry eye syndrome treatment market: Sales channel segment dashboard
Fig. 25 U.S. dry eye syndrome treatment market: Sales channel market share analysis, 2024 & 2030
Fig. 26 U.S. dry eye syndrome treatment market: Distribution channel segment dashboard
Fig. 27 U.S. dry eye syndrome treatment market: Distribution channel market share analysis, 2024 & 2030
Fig. 28 Company categorization
Fig. 29 Company market position analysis
Fig. 30 Strategic framework